1. Utilizing New Technologies and Insulins for a Tighter Grip on PPG

3. Introduction/Overview

4. Major Mechanisms Linking Elevated PPG to Diabetes Complications

5. Recommended Targets for PPG

6. Diabetes Care Technologies: "Game Changers"

7. Patient Case Study

8. Smart Devices: CGM-Augmented Insulin Treatment

9. CGM From the Patient's Perspective

10. Optimizing Approaches to PPG Control

11. CSII: Insulin Pumps

12. Insulin Replacement Therapy Aims to Recreate the Normal Blood Insulin Profile

13. Ultra-Fast-Acting Insulins: Approaching a More Exact Physiologic Insulin Profile

14. Ultra-Fast-Acting Prandial Insulins

15. Trial of a Hybrid Closed-Loop Insulin Delivery System

16. The Challenge of Mimicking the Physiologic Response to Mealtime Glucose

17. BioChaperone® Lispro: Faster Insulin Kinetics Compared With Lispro (Injection)

18. Faster Aspart Pooled Analysis: Onset and Offset of Insulin Action

19. Patients With T1DM Who May Be Candidates for Ultra-Fast-Acting Insulins

20. Glucose-Monitoring With the FreeStyle Libre™ Device

21. Onset® 1: Study Design

22. Onset® 1: PPG (Test Meal)

23. Onset® 1: Faster-Acting Insulin Aspart Administered Postmeal

24. Onset® 4: Incidence of Hyperglycemia

25. Onset® 5: PPG Increment Results After a Standardized Meal Test

26. Scale of Self-Reported Psychological Complaints: Controls vs Patients With T1DM

27. Summary and Conclusions